Sensyne Health Plc Enters Into An Agreement With A Fortune 200 Company

  • Oct 07, 2019 BST
  • Team Kalkine
  • Sensyne Health Plc (SENS) has entered into an agreement with a Fortune 200 company and a data infrastructure specialist to launch and scale its digital health products under licence in the U.S.
  • The company will develop Clinical AI-as-a-service solutions that will use AI (artificial intelligence) and prognostic analytics to help foil and manage a variety of chronic health conditions.
  • On 7th October 2019, at the time of writing, GMT 12:22 PM, SENS shares were trading at GBX 107.50, up by 5.00 points or 4.88 per cent against the previous day closing price.

With Bank of England reducing the interest rates to a historic low level, the spotlight is back on diverse investment opportunities. 

Amidst this, are you getting worried about these falling interest rates and wondering where to put your money?

Well! Team Kalkine has a solution for you. You still can earn a relatively stable income by putting money in the dividend-paying stocks.

We think it is the perfect time when you should start accumulating selective dividend stocks to beat the low-interest rates, while we provide a tailored offering in view of valuable stock opportunities and any dividend cut backs to be considered amid scenarios including a prolonged market meltdown.

To know more about these dividend stocks, click here

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK